HALF YEARLY RESULTS
Gland Pharma Ltd.
BSE
Jun 06
1640.65
+10.55 (+ 0.65%)
Volume
2361
Prev. Close
1630.10
Open Price
1649.30
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jun 06
1642.00
+8.40 (+ 0.51%)
Volume
95999
Prev. Close
1633.60
Open Price
1644.00
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Halfyearly Results
for the last 5 years.
|
ISIN No
|
INE068V01023
|
Market Cap. ( ₹ in Cr. )
|
27053.00
|
P/BV
|
3.08
|
Book Value ( ₹ )
|
533.39
|
|
BSE Code
|
543245
|
52 Week High/Low ( ₹ )
|
2221/1278
|
FV/ML
|
1/1
|
P/E(X)
|
38.73
|
|
NSE Code
|
GLANDEQ
|
Book Closure
|
14/08/2025
|
EPS ( ₹ )
|
42.40
|
Div Yield (%)
|
0.00
|
(₹ in Crs.)
| Net Sales/Income from operations | 2041.14 | 2075.01 | 2272.69 | 1894.74 | 1711.32 |
| Total Income From Operations | 2041.14 | 2075.01 | 2272.69 | 1894.74 | 1711.32 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 818.30 | 767.56 | 861.31 | 848.43 | 871.57 |
| Purchase of Traded Goods | 5.25 | 9.24 | 13.21 | 9.93 | 7.06 |
| Increase/Decrease in Stocks | -41.75 | 172.00 | 130.66 | -43.23 | -92.55 |
| Power & Fuel | 60.89 | 59.49 | 57.52 | 0.00 | 29.51 |
| Employees Cost | 225.06 | 213.97 | 207.15 | 202.79 | 200.55 |
| Depreciation | 86.84 | 82.43 | 82.89 | 79.22 | 75.15 |
| Other Expenses | 188.13 | 195.41 | 200.51 | 270.36 | 242.07 |
| Total Expenses | 1342.71 | 1500.09 | 1553.26 | 1367.49 | 1333.36 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 698.43 | 574.92 | 719.43 | 527.24 | 377.96 |
| Other Income | 108.78 | 106.29 | 90.35 | 76.32 | 100.45 |
| P/L Before Interest, Excpt. Items & Tax | 807.21 | 681.21 | 809.78 | 603.56 | 478.41 |
| Interest | 21.75 | 1.08 | 5.33 | 2.51 | 4.80 |
| P/L Before Exceptional Items & Tax | 785.45 | 680.13 | 804.44 | 601.05 | 473.61 |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | -56.46 |
| P/L Before Tax | 785.45 | 680.13 | 804.44 | 601.05 | 417.15 |
| Tax | 200.33 | 175.50 | 206.23 | 155.95 | 110.41 |
| P/L After Tax from Ordinary Activities | 585.12 | 504.63 | 598.22 | 445.11 | 306.74 |
| Net Profit/Loss For the Period | 585.12 | 504.63 | 598.22 | 445.11 | 306.74 |
| | | | | | |
| Equity Share Capital | 16.48 | 16.48 | 16.47 | 16.47 | 16.47 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 35.51 | 30.63 | 36.32 | 27.03 | 18.62 |
| Diluted EPS (Rs.) | 35.50 | 30.63 | 36.32 | 27.02 | 18.62 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 35.51 | 30.63 | 36.32 | 27.03 | 18.62 |
| Diluted EPS (Rs.) | 0.00 | 30.63 | 0.00 | 27.02 | 0.00 |
| | | | | | |
| PBITOE Margin (%) | 34.21 | 27.70 | 31.65 | 27.82 | 22.08 |
| PBTE Margin (%) | 38.48 | 32.77 | 35.39 | 31.72 | 27.67 |
| PBT Margin (%) | 38.48 | 32.77 | 35.39 | 31.72 | 24.37 |
| PAT Margin (%) | 28.66 | 24.31 | 26.32 | 23.49 | 17.92 |